Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin

Abstract

Natural products have been used for the treatment of various diseases such as cancer. Curcumin (CUR) and sulforaphane (SF) have anti-cancer effects, but their application is restricted because of their low water solubility and poor oral bioavailability. To improve the bioavailability and solubility of SF and CUR, we performed an advanced delivery of SF and CUR with PEGylated gold coated FeO magnetic nanoparticles (PEGylated FeO@Au NPs) to endorse SF and CUR maintenance as an effective and promising antitumor drugs. The structure of the synthesized nanocarrieris evaluated by, transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FT-IR). The results revealed that the size of NPs was 20 nm. They were mono-dispersed in water, with high drug-loading capacity and stability. CUR and SF were encapsulated into NPs with loading capacity of 16.32±0.023% and 15.74±0.015% and entrapment efficiency of 74.57±0.14% and 72.20±0.18% respectively. The in-vitro study of SF and CUR loaded PEGylated FeO@Au NPs on human breast adenocarcinoma cell line (SK-BR-3) confirmed that cytotoxicity of SF and CUR can enhance when they are loaded on PEGylated FeO@Au NPs in comparison to Free SF and void CUR. The results of flow cytometry and real-time PCR shown that nano-carriers can increase therapeutic effects of SF and CUR by apoptosis and necrosis induction as well as inhibiting of migration in SK-BR-3 cell line.

Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer

“…However, low bioavailability of phytochemicals is a major challenge. To overcome this, liposomal and other nanoformulations are being currently used to enhance their solubility in water and thus their bioavailability [ 148 , 149 , 150 , 151 ]. As phytochemicals are derived from natural sources, they are generally considered to be safe.…”

Potential amelioration of nicotine‐induced toxicity by nanocurcumin

“…The clinical efficacy of curcumin in human subjects is limited due to its undesirable pharmacokinetic properties although; some clinical trials have unequivocally demonstrated the safety and efficacy of turmeric in human subjects (Gupta et al, ). Scientists are trying to improve the pharmacokinetic properties of curcumin for translating its wide range of activities into clinical benefits, e.g., formulation and applications of nanocurcumin (Danafar, ; Danafar, Sharafi, Askarlou, & Manjili, ; Kheiri Manjili et al, ; Nosrati, Sefidi, Sharafi, Danafar, & Manjili, ). Nanoparticles are a novel drug delivery mode on account of its high bioavailability in aqueous media, controlled drug release property, and higher physical stability and drug loading (Shaikh, Ankola, Beniwal, Singh, & Kumar, ; Yadav, Lomash, Samim, & Flora, ).…”

“…2017;Danafar, Sharafi, Askarlou, & Manjili, 2017;Kheiri Manjili et al, 2017;Nosrati, Sefidi, Sharafi, Danafar, & Manjili, 2018). Nanoparticles are a novel drug delivery mode on account of its high bioavailability in aqueous media, controlled drug release property, and higher physical stability and drug loading(Shaikh, Ankola, Beniwal, Singh, & Kumar, 2009;Yadav, Lomash, Samim, & Flora, 2012).…”

<p>Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications</p>

“…In recent years, porous materials, such as mesoporous silica nanoparticles (MSNs), metal-organic frameworks 89 and iron oxide-gold nanoparticles 90 have been widely used in drug delivery. Kresge et al first used surfactants as structure directing agents to prepare highly ordered MSNs with uniform pore sizes in 1992.…”